Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$100.21 AUD
Change Today -0.56 / -0.56%
Volume 1.5M
As of 2:10 AM 08/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David Westbrook Anstice

Independent Director, Member of Nomination Committee, Member of Human Resources & Remuneration Committee and Member of Innovation & Development Committee, CSL Ltd.
AgeTotal Calculated CompensationThis person is connected to 134 board members in 6 different organizations across 5 different industries.

See Board Relationships
67$563,393

Background*

Mr. David Westbrook Anstice served as the President of MSD K.K. Mr. Anstice served as Executive Vice President of Strategy Initiatives at Merck & Co. Inc., from September 2006 to September 2008. He served as the President of Human Health of Merck & Co., Inc. from January 2003 to September 2006 and was responsible for its prescription drug business in Japan, Latin America, Canada, Australia, New Zealand and its joint venture relationship with Schering-Plough. He spent ...

Read Full Background

Corporate Headquarters*

45 Poplar Road
Parkville, Victoria 3052

Australia

Phone: 61 3 9389 1911
Fax: 61 3 9389 1434

Board Members Memberships*

Representative Director
Trustee
Director
2008-Present
Independent Director, Chairman of Compensation Committee and Member of Limited Compensation Sub Committee
2008-Present
Independent Director, Member of Nomination Committee, Member of Human Resources & Remuneration Committee and Member of Innovation & Development Committee
2008-Present
Director

Education*

Bachelor's Degree 1970
University Of Sydney

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$94,000
Total Calculated Compensation$563,393
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSL:AU A$100.21 AUD -0.56

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Vinita Gupta Chief Executive Officer, Executive Director and Member of Risk Management Committee
Lupin Limited
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSL LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.